30-Day Morbidity and Reoperation Following Midurethral Sling: Analysis of 8772 Cases Using a National Prospective Database

Keyphrases

• 30-day Complications 20%
• 30-day Mortality 100%
• 30-day Readmission 20%
• Baseline Characteristics 20%
• Bladder 20%
• Body Mass Index 20%
• Common Complications 20%
• Complication Risk 20%
• Diabetic 20%
• Frailty 40%
• Gynaecological Patients 20%
• Gynecologic Surgery 20%
• Gynecologist 80%
• Logistic Regression Analysis 20%
• Midurethral Sling 100%
• National Surgical Quality Improvement Program (NSQIP) 20%
• Operative Time 40%
• Overall Morbidity 20%
• Postoperative Outcomes 20%
• Prospective Database 100%
• Readmission Risk 20%
• Reoperation 100%
• Residency 20%
• Resident Participation 20%
• Risk Factors 20%
• Sling Revision 20%
• Steroid Use 20%
• Surgeons 20%
• Urethra 20%
• Urinary Obstruction 20%
• Urinary Symptoms 20%
• Urinary Tract Infection 60%
• Urologic 20%
• Urological Surgery 20%
• Urologists 80%

Medicine and Dentistry

• Bladder 25%
• Body Mass Index 25%
• Diabetes Mellitus 25%
• Frailty 50%
• Logistic Regression Analysis 25%
• Operation Duration 50%
• Quality Improvement 25%
• Reoperation 100%
• Surgeon 25%
• Urinary System 25%
• Urinary Tract Infection 75%
• Urinary Tract Obstruction 25%
• Urologist 100%